Search research articles
Contact Us
Filters
Showing results (121-130 of 140) with videos related to
Page
of 14
Sort By:
Stroke
|
May 21, 2020
Delays in Stroke Onset to Hospital Arrival Time During COVID-19
Kay-Cheong Teo, William C Y Leung, Yuen-Kwun Wong, et al.
Immunity
|
May 4, 2024
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Neuro-Oncology
|
January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases
Stephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 6, 2010
Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity
Kevin K-C Liu, Bruce A Lefker, Mark A Dombroski, et al.
Pigment Cell & Melanoma Research
|
January 10, 2020
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions
Isabella C Glitza, Keiran S M Smalley, Priscilla K Brastianos, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity
Kevin K-C Liu, JinJiang Zhu, Graham L Smith, et al.
Frontiers in Neurology
|
May 7, 2024
Impact of renal function variability on long-term prognosis in ischemic stroke patients with atrial fibrillation
Xiao Wang, Chun-Fung Sin, Kay-Cheong Teo, et al.
Neuro-Oncology
|
February 25, 2022
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
Vincent Law, Zhihua Chen, Francesca Vena, et al.
Cancer Discovery
|
February 27, 2025
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation
Alessio Ugolini, Alessandra De Leo, Xiaoqing Yu, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design
Hengmiao Cheng, Chunze Li, Simon Bailey, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 140) with videos related to
Sort By:
Page
of 14
Stroke
|
May 21, 2020
Delays in Stroke Onset to Hospital Arrival Time During COVID-19
Kay-Cheong Teo, William C Y Leung, Yuen-Kwun Wong, et al.
Immunity
|
May 4, 2024
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Neuro-Oncology
|
January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases
Stephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 6, 2010
Orally active and brain permeable proline amides as highly selective 5HT2c agonists for the treatment of obesity
Kevin K-C Liu, Bruce A Lefker, Mark A Dombroski, et al.
Pigment Cell & Melanoma Research
|
January 10, 2020
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions
Isabella C Glitza, Keiran S M Smalley, Priscilla K Brastianos, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity
Kevin K-C Liu, JinJiang Zhu, Graham L Smith, et al.
Frontiers in Neurology
|
May 7, 2024
Impact of renal function variability on long-term prognosis in ischemic stroke patients with atrial fibrillation
Xiao Wang, Chun-Fung Sin, Kay-Cheong Teo, et al.
Neuro-Oncology
|
February 25, 2022
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma
Vincent Law, Zhihua Chen, Francesca Vena, et al.
Cancer Discovery
|
February 27, 2025
Functional Reprogramming of Neutrophils within the Brain Tumor Microenvironment by Hypoxia-Driven Histone Lactylation
Alessio Ugolini, Alessandra De Leo, Xiaoqing Yu, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design
Hengmiao Cheng, Chunze Li, Simon Bailey, et al.
Page
of 14